Armstrong Fleming & Moore’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-209
Closed -$220K 101
2024
Q3
$220K Hold
209
0.13% 90
2024
Q2
$220K Hold
209
0.14% 86
2024
Q1
$201K Buy
+209
New +$201K 0.14% 89